AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 39.25 USD 4.92%
Market Cap: $2B

AxoGen Inc
Other Non-Cash Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

AxoGen Inc
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
AxoGen Inc
NASDAQ:AXGN
Other Non-Cash Items
$34.2m
CAGR 3-Years
21%
CAGR 5-Years
22%
CAGR 10-Years
33%
Boston Scientific Corp
NYSE:BSX
Other Non-Cash Items
$522m
CAGR 3-Years
-1%
CAGR 5-Years
77%
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Other Non-Cash Items
$332.2m
CAGR 3-Years
14%
CAGR 5-Years
23%
CAGR 10-Years
32%
Stryker Corp
NYSE:SYK
Other Non-Cash Items
$586m
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Other Non-Cash Items
$729m
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
4%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Non-Cash Items
$730m
CAGR 3-Years
9%
CAGR 5-Years
16%
CAGR 10-Years
13%
No Stocks Found

AxoGen Inc
Glance View

Market Cap
2B USD
Industry
Health Care

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. The company is headquartered in Alachua, Florida and currently employs 428 full-time employees. Its platform for peripheral nerve repair features a comprehensive portfolio of products, including Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Avive Soft Tissue Membrane and Axotouch Two-Point Discriminator. Its products are used by surgeons during surgical interventions to repair a variety of physical nerve damage or transection throughout the body, which ranges from a simple laceration of a finger to a complex brachial plexus injury, as well as nerve injuries caused by dental, orthopedic, and other surgical procedures. Its Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Its portfolio of products is available in the United States, Canada, Germany, Spain, South Korea, and several other countries.

AXGN Intrinsic Value
12.16 USD
Overvaluation 69%
Intrinsic Value
Price $39.25

See Also

What is AxoGen Inc's Other Non-Cash Items?
Other Non-Cash Items
34.2m USD

Based on the financial report for Dec 31, 2025, AxoGen Inc's Other Non-Cash Items amounts to 34.2m USD.

What is AxoGen Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 10Y
33%

Over the last year, the Other Non-Cash Items growth was 92%. The average annual Other Non-Cash Items growth rates for AxoGen Inc have been 21% over the past three years , 22% over the past five years , and 33% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett